Abstract: The present invention generally relates to the field of probiotic bacteria. In particular, the present invention relates to natural derivatives of the Lactobacillus johnsonii strain CNCM I-1225 with improved properties. For example, the present invention relates to a natural derivative of the Lactobacillus johnsonii strain CNCM I-1225 that is deficient in D-lactic acid production and exhibits an improved viability during product storage.

Abstract: The present invention generally relates to the field of probiotic bacteria. In particular, the present invention relates to natural derivatives of the Lactobacillus johnsonii strain CNCM I-1225 with improved properties. For example, the present invention relates to a natural derivative of the Lactobacillus johnsonii strain CNCM I-1225 that is deficient in D-lactic acid production and exhibits an improved viability during product storage.

Abstract: The present invention generally relates to the field of proteinases and more specifically to chymotrypsin. In particular, the present invention relates to recombinant porcine chymotrypsin and its use in food applications.

Abstract: The present invention generally relates to edible compositions and methods to produce them. In particular, the present invention relates to the enzymatic modulation of macron utrients and to food compositions containing such modulated macronutrients. One embodiment of the present invention is a method for modulating macronutrients comprising the steps of producing at least one synthetic gene coding for at least one enzyme or a functional part thereof capable of modulating macronutrients, expressing the at least one enzyme or a functional part thereof, and bringing the macronutrients into contact with the at least one enzyme or a functional part thereof exhibiting the enzymatic activity.

Abstract: The present invention pertains to the use of the DNA sequence of a Lactobacillus johnsonii strain, in particular to its genomic sequence for elucidating interactions of micro-organism with hosts they colonize, and moreover for elucidating the basis of probiotic properties exhibited by such strain. In addition, the present invention also relates to methods of detecting nucleic acids or polypeptides of Lactobacilli and related species, respectively. A data carrier is provided comprising nucleotide sequences and/or polypeptide sequences of La1.

Abstract: A DNA fragment derived from coffee encoding at least one enzyme involved in the hydrolysis of polysaccharides comprising pure or branched mannan molecules linked to each other via a ? (1?4) linkage, and which has the the nucleic acid sequence SEQ ID NO.:1 or which is homologous to or hybridizes to a fragment of DNA having the nucleic acid sequence SEQ ID NO.:1.

Abstract: A novel microorganism of the genus Bifidobacterium longum, in particular to its genomic and plasmid sequence and to a method of producing polypeptides of said Bifidobacterium, respectively. Also methods of detecting these nucleic acids or polypeptides, respectively. A data carrier is provided comprising nucleotide sequences and/or polypeptide sequences of NCC2705. In addition, the Bifidobacterium longum strain NCC2705 and also to food and pharmaceutical compositions containing said Bifidobacterium or active components thereof for the prevention and/or treatment of diarrhoea brought about by rotaviruses and pathogenic bacteria are provided.

Abstract: A DNA fragment derived from coffee encoding at least one enzyme involved in the hydrolysis of polysaccharides comprising pure or branched mannan molecules linked to each other via a ? (1?4) linkage, and which has the the nucleic acid sequence SEQ ID NO.:1 or which is homologous to or hybridizes to a fragment of DNA having the nucleic acid sequence SEQ ID NO.:1.

Abstract: The present invention pertains to novel strains of the Bacillus subtilis group capable of fermenting beans, which are essentially devoid of any iso-valeric acid production. The present invention especially relates to novel strains of Bacillus natto, in which one or more genes involved in the biosynthetic pathway for the production of iso-valeric acids are essentially non-functional.

Abstract: The present invention pertains to a novel micro-organism of the genus Bifidobacterium longum, in particular to its genomic and plasmid sequence and to a method of producing polypeptides of said Bifidobacterium, respectively. The invention also relates to methods of detecting these nucleic acids or polypeptides, respectively. A data carrier is provided comprising nucleotide sequences and/or polypeptide sequences of NCC2705. In addition, the present invention pertains to the Bifidobacterium longum strain NCC2705 and also to food and pharmaceutical compositions containing said Bifidobacterium or active components thereof for the prevention and/or treatment of diarrhoea brought about by rotaviruses and pathogenic bacteria.

Abstract: A DNA fragment derived from coffee encoding at least one enzyme involved in the hydrolysis of polysaccharides comprising pure or branched mannan molecules linked to each other via a &bgr; (1→4) linkage, and which has the the nucleic acid sequence SEQ ID NO.:1 or which is homologous to or hybridizes to a fragment of DNA having the nucleic acid sequence SEQ ID NO.:1.

Abstract: The present invention pertains to novel strains of the Bacillus subtilis group capable of fermenting beans, which are essentially devoid of any iso-valeric acid production. The present invention especially relates to novel strains of Bacillus natto, in which one or more genes involved in the biosynthetic pathway for the production of iso-valeric acids are essentially non-functional.

Abstract: Recombinant strains of L. johnsonii which have capacities of surviving passage through the intestine, adhering to human intestinal cells and increasing phagocytosis of macrophages and which have a sequence of gene coding which is an L. johnsonii strain sequence of gene coding for D-lactate dehydrogenase modified so that the recombinant strain produces only L(+)-lactate.

Abstract: A recombinant strain of L. johnsonii which has capacities of surviving passage through the intestine, adhering to human intestinal cells and increasing phagocytosis of macrophages and which has a gene sequence code for D-lactate dehydrogenase which is a modified L. johnsonii gene sequence code and which produces only L(+)-lactate.